Lack of evidence in reducing risk of MRONJ after teeth extractions with systemic antibiotics
- 1 January 2021
- journal article
- review article
- Published by Nihon University School of Dentistry in Journal of Oral Science
- Vol. 63 (3), 217-226
- https://doi.org/10.2334/josnusd.21-0016
Abstract
A systematic review was carried out to identify if periprocedural administration of systemic antibiotics could decrease risk of medication-related osteonecrosis of the jaws (MRONJ) in patients under antiresorptive and/or biologic agents for teeth extraction. PubMed/MEDLINE and Scopus were systematically searched for case-series with more than 10 patients, retrospective/prospective studies, and trials concerning this issue. Manual searching of references from previous reviews was also carried out. Of 1,512 results, 17 studies were included, focusing on antibiotics for extraction in patients under intravenous bisphosphonates (8 studies), oral bisphosphonates (2 studies), oral and intravenous bisphosphonates (6 studies), and denosumab (1 study), of which 12 performed dental extraction with surgical flap. With no trials found, “quality in prognosis studies” (QUIPS) tool was used to evaluate risk of bias. First-line treatment was 2-3 grams of oral amoxicillin in 76.4% of studies; 300-600 mg of clindamycin was the alternative treatment in 23.5% of studies. Treatment ranged from 3 to 20 days, consisting of 6-7 days in 47% of studies. No microbiologic insight was provided. A significantly higher risk of MRONJ for patients unexposed to antibiotics was provided in one retrospective study. QUIPS tool revealed moderate-high risk of bias. With empirical data from bias-carrying, heterogeneous observational studies, the validity of antibiotics is yet to be established.Keywords
This publication has 41 references indexed in Scilit:
- Sunitinib related osteonecrosis of jaw: a case reportOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2012
- Preventive Protocol for Tooth Extractions in Patients Treated With Zoledronate: A Case SeriesJournal of Oral and Maxillofacial Surgery, 2011
- Initial Experience on the Outcome of Teeth Extractions in Intravenous Bisphosphonate-Treated Patients: A Cautionary ReportJournal of Oral and Maxillofacial Surgery, 2011
- Occurrence of Bisphosphonate-Related Osteonecrosis of the Jaw After Surgical Tooth ExtractionJournal of Oral and Maxillofacial Surgery, 2010
- Osteonecrosis of the jaws induced by anti-RANK ligand therapyBritish Journal of Oral and Maxillofacial Surgery, 2010
- Tooth Extraction in Patients Taking Intravenous Bisphosphonates: A Preventive Protocol and Case SeriesJournal of Oral and Maxillofacial Surgery, 2010
- American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws—2009 UpdateJournal of Oral and Maxillofacial Surgery, 2009
- Actinomycosis: Diagnosis and ManagementSouthern Medical Journal, 2008
- Osteonecrosis of the Jaw Related to BevacizumabJournal of Clinical Oncology, 2008
- Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonatesLeukemia & Lymphoma, 2008